Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Bio-ethics
|
Not currently available
The Public Health Emergency Medical Countermeasures Enterprise - Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (Paperback)
Loot Price: R1,333
Discovery Miles 13 330
|
|
The Public Health Emergency Medical Countermeasures Enterprise - Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
During public health emergencies such as pandemic influenza
outbreaks or terrorist attacks, effective vaccines, drugs,
diagnostics, and other medical countermeasures are essential to
protecting national security and the public's well-being. The
Public Health Emergency Medical Countermeasures Enterprise
(PHEMCE)-a partnership among federal, state, and local governments;
industry; and academia-is at the forefront of the effort to develop
and manufacture these countermeasures. However, despite the
PHEMCE's many successes, there are still serious challenges to
overcome. Government-funded medical research is not always focused
on countermeasures for the most serious potential threats, and it
is difficult to engage pharmaceutical and biotechnology companies
to develop and manufacture medical countermeasures that have a
limited commercial market. At the request of the Secretary of the
U.S. Department of Health and Human Services and the Assistant
Secretary for Preparedness and Response, the IOM held a workshop
February 22-24, 2010, to address challenges facing the PHEMCE.
Workshop participants discussed federal policies and procedures
affecting the research, development, and approval of medical
countermeasures and explored opportunities to improve the process
and protect Americans' safety and health. Table of Contents Front
Matter Workshop Summary Appendix A: References Appendix B: Workshop
Agenda Appendix C: Registered Workshop Attendees Appendix D: Case
Studies of HHS Chemical, Biological, Radiological, and Nuclear
Medical Countermeasure Development Programs, Executive Summary
Appendix E: Synthesis of Business Models and Economic and Market
Incentives for Vaccines and Therapeutics
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.